StatLab Medical Products Acquires CellPath Ltd.

Leica Biosystems Acquires StatLab Medical Products

September 28, 2026

Medical Devices

Leica Biosystems, a Danaher company, completed its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity on September 28, 2026. StatLab’s pre-analytical pathology consumables and equipment add specimen collection and preparation capabilities to Leica Biosystems’ pathology portfolio, broadening its offering from specimen collection through digital imaging and AI-enabled diagnosis.

Leica Biosystems to Acquire StatLab Medical Products From Linden Capital Partners and Audax Private Equity

July 14, 2026

Medical Devices

Leica Biosystems, a Danaher company, signed a definitive agreement to acquire StatLab Medical Products. StatLab is currently owned by Linden Capital Partners and Audax Private Equity, and the transaction is subject to customary closing conditions. Financial terms were not disclosed and the deal was expected to close by the end of 2026.

StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS

August 13, 2025

Medical Devices

StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.

StatLab Medical Products Acquires Pyramid Innovation

August 10, 2021

Medical Devices

StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, has acquired Pyramid Innovation, a Sussex-based developer of pathology slide and cassette printers. The deal expands StatLab’s instrument manufacturing capabilities and strengthens its laboratory automation product lineup while maintaining Pyramid’s operations in Sussex under founder Tom Hughes.

Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products

January 12, 2021

Medical Devices

Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.

StageBio Acquires TPL Path Labs

October 21, 2020

Healthcare Services

StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.